6 results
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Potential Treatment ... Agents for Treatment ... difficile infection ... Episode #Pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... Therapy for Treating Clostridium ... difficile Infection ... #Prevention #Treatment ... #HIVAIDS #pharmacology
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Infection (CDI) ... Toxic Megacolon, Shock ... can be community-acquired ... Ileus, Megacolon, Shock ... #Clostridium #Infection
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... antifungals are required ... candida #mucosal #IDSA ... opportunistic #infections ... #HIVAIDS #pharmacology
Potential Treatment Agents for Treatment of the Primary Clostridium difficile infection Episode
Proven efficacy:
 • Vancomycin -
Potential Treatment ... of the Primary Clostridium ... difficile infection ... #management #pharmacology ... #idsa #table
IDSA Recommendations for Preventing and Managing Microsporidiosis in HIV-AIDS
Preventing Chronic Microsporidiosis:
 • Because chronic microsporidiosis occurs
IDSA Recommendations ... : • The best treatment ... Microsporidiosis #IDSA ... #Prevention #Treatment ... #HIVAIDS #pharmacology